Energy Products Inc

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teladoc, Verrica, and Apyx and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 9, 2022
New Drug Application, Energy Products Inc, Company, TDOC, Teladoc Health, Amazon (company), CMO, Tax, Mental health, LLC, EBITDA, Advanced Energy, Food, News, Endpoint security, D2C, Coagulation, FDA, Growth, GLOBE, Defendant, Molluscum contagiosum, NYSE, Depreciation, NASDAQ, BetterHelp, Industry, Walmart, Lists of schools in England, NDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Risk management, Pharmaceutical industry, Audit, Animal, P.C

Teladoc provides virtual healthcare services in the U.S. and internationally through Business-to-Business (B2B) and Direct-to-Consumer (D2C) distribution channels.

Key Points: 
  • Teladoc provides virtual healthcare services in the U.S. and internationally through Business-to-Business (B2B) and Direct-to-Consumer (D2C) distribution channels.
  • The Company offers its customers various virtual products and services addressing, among other medical issues, mental health through its BetterHelp D2C product, and chronic conditions.
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • For more information on the Apyx class action go to: https://bespc.com/cases/APYX
    About Bragar Eagel & Squire, P.C.

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Apyx Medical Corporation (APYX)

Retrieved on: 
Thursday, June 9, 2022
Legal, Professional Services, Steps, Energy Products Inc, Company, Securities Exchange Act of 1934, Advanced Energy, News, Coagulation, FDA, NASDAQ, Person, Complaint, Pharmaceutical industry

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Apyx Medical Corporation (NASDAQ: APYX) securities between May 12, 2021 and March 11, 2022, for violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Apyx Medical Corporation (NASDAQ: APYX) securities between May 12, 2021 and March 11, 2022, for violations of the Securities Exchange Act of 1934.
  • Apyx claims to be an advanced energy technology company with products in the cosmetic and surgical markets.
  • If you would like more information about Apyx Medical Corporation's misconduct, click here .
  • On March 14, 2022, Apyx disclosed that the FDA would be posting a Medical Device Safety Communication (MDSC) related to the Companys Advanced Energy Products.

OCA Wins "Energy Product of the Year" at 2022 Mindful Awards

Retrieved on: 
Wednesday, June 8, 2022
Mindfulness, Life, Sensation, Citric acid, Caffeine, Radio, Nature, Burn, Energy, Drink, Athlete, Erewhon, Energy Products Inc, Sale, Growth, Marc Anthony, Health, Albertsons, Instacart, Personality, Leadership, LOS, Plant, Anthony, Grammy Awards, Vitacost, Instagram, Taste, Year, OCA, Toronto Blue Jays, Video game, Coffee, Soft drink, Online shopping, Music, Facebook, New York Yankees, Snack, Kroger, Amazon

LOS ANGELES, June 8, 2022 /PRNewswire-PRWeb/ -- The 2022 Mindful Awards, an independent recognition platform highlighting conscious companies and products that mindfully make waves in the ever-expanding world of consumer-packaged goods, today announced organic plant-based energy drink OCA as the winner of "Energy Product of the Year" in the Beverage category. OCA is the first product to launch under WeBelivMagnus umbrella, the result of a collaboration between Beliv (a leader in the global beverage industry with a portfolio of over 40 brands in 35 countries), led by Carlos Sluman, and Magnus Media, (the media venture founded by Grammy-Award-winning artist and Latin music icon Marc Anthony).

Key Points: 
  • OCA offers consumers a tasty solution to increase energy while also treating the body the way it deserves.
  • "Thank you to the 2022 Mindful Awards for selecting OCA as the Energy Product of the Year," said Gabriela Rameriz, Head of OCA.
  • We are proud to honor OCA as this year's 'Energy Product of the Year' at the 2022 Mindful Awards," said Travis Grant, Managing Director, Mindful Awards.
  • The Mindful Awards organization is devoted to honoring mindful companies in the consumer-packaged goods industry that are setting the foundation for our future.

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of APYX Medical Corporation (APYX) Investors

Retrieved on: 
Wednesday, June 8, 2022
Legal, Professional Services, Energy Products Inc, District court, Company, Advanced Energy, Food, Court, Douglas v. U.S. District Court ex rel Talk America, News, Coagulation, FDA, NASDAQ, Lists of schools in England, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LLP, Kirby, Medical device, Private investigator

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Florida on behalf of those who acquired APYX Medical Corporation (Apyx Medical) (NASDAQ: APYX ) securities from May 12, 2021 through March 11, 2022, both dates inclusive (the Class Period).

Key Points: 
  • The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Florida on behalf of those who acquired APYX Medical Corporation (Apyx Medical) (NASDAQ: APYX ) securities from May 12, 2021 through March 11, 2022, both dates inclusive (the Class Period).
  • Investors have until August 5, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Apyx Medical is an energy technology company develops products in the cosmetic and surgical markets.
  • Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

Retrieved on: 
Wednesday, June 8, 2022
Legal, Professional Services, Energy Products Inc, Time, Company, Advanced Energy, Food, Court, News, Coagulation, FDA, Defendant, NASDAQ, Twitter, Law, Lists of schools in England, Regulation of tobacco by the U.S. Food and Drug Administration, Person, Suite, Risk management

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).

Key Points: 
  • The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • Apyx investors have until August 5, 2022 to file a lead plaintiff motion.
  • On March 14, 2022, Apyx disclosed that the U.S. Food and Drug Administration (FDA) would be posting a Medical Device Safety Communication (MDSC) related to the Companys Advanced Energy Products.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

APYX MEDICAL CORPORATION (NASDAQ: APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation (NASDAQ: APYX)

Retrieved on: 
Wednesday, June 8, 2022
Lists of action films, Energy Products Inc, District court, Company, Securities Exchange Act of 1934, Advanced Energy, Food, Court, News, The Legal 500, Coagulation, Investment, FDA, GLOBE, Advertising, Labour government, NASDAQ, Helium, NEW, Lists of schools in England, Regulation of tobacco by the U.S. Food and Drug Administration, LLP, Tobacco, Pharmaceutical industry, Online gambling, Security (finance)

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Apyx Medical Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • If you purchased APYX securities, and/or would like to discuss your legal rights and options please visit Apyx Medical Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation (APYX)

Retrieved on: 
Tuesday, June 7, 2022
Energy Products Inc, District court, Company, Complaint, Advanced Energy, Food, News, Coagulation, FDA, GLOBE, NASDAQ, Regulation of tobacco by the U.S. Food and Drug Administration, Pharmaceutical industry

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX) in the United States District Court for the Middle District of Florida on behalf of investors who purchased Apyx stock between May 12, 2021 and March 11, 2022, inclusive (the Class Period).

Key Points: 
  • NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX) in the United States District Court for the Middle District of Florida on behalf of investors who purchased Apyx stock between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • On March 14, 2022, Apyx disclosed that the U.S. Food and Drug Administration (FDA) would be posting a Medical Device Safety Communication (MDSC) related to the Companys Advanced Energy Products.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Apyx Medical Corporation – APYX

Retrieved on: 
Tuesday, June 7, 2022
Energy Products Inc, Company, Advanced Energy, Food, News, Coagulation, FDA, GLOBE, NASDAQ, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LLP, Pomerantz, Private investigator

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (Apyx or the Company) (NASDAQ:APYX).

Key Points: 
  • NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (Apyx or the Company) (NASDAQ:APYX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Apyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

APYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Apyx Medical Corporation

Retrieved on: 
Tuesday, June 7, 2022
Legal, Professional Services, Energy Products Inc, District court, Time, Company, Securities Exchange Act of 1934, Advanced Energy, Food, Court, News, Person, FDA, Defendant, NASDAQ, Twitter, Law, Lists of schools in England, Regulation of tobacco by the U.S. Food and Drug Administration, Suite, Risk management

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle District of Florida captioned Hattaway v. Apyx Medical Corporation, et al., Case No.

Key Points: 
  • The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle District of Florida captioned Hattaway v. Apyx Medical Corporation, et al., Case No.
  • 22-cv-1298, on behalf of persons and entities that purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act).
  • Investors are hereby notified that they have until August 5, 2022 to move the Court to serve as lead plaintiff in this action.

APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 7, 2022
Legal, Professional Services, Energy Products Inc, District court, Company, Advanced Energy, Food, Court, Jeanne Eagels, News, Telephone, Coagulation, FDA, Defendant, NASDAQ, Lists of schools in England, P.C, Regulation of tobacco by the U.S. Food and Drug Administration, Person, Risk management

Investors have until August 5, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until August 5, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On March 14, 2022, Apyx disclosed that the U.S. Food and Drug Administration (FDA) would be posting a Medical Device Safety Communication (MDSC) related to the Companys Advanced Energy Products.
  • On this news, the Companys stock fell $4.02, or 40.6%, to close at $5.88 per share on March 14, 2022, on unusually heavy trading volume.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.